Potential neuroprotective therapy for glaucomatous optic neuropathy (Q41716847)

7 October 2017

1 reference

title

Potential neuroprotective therapy for glaucomatous optic neuropathy (English)

1 reference

7 October 2017

Yoles E

1

1 reference

PubMed ID

9493279

7 October 2017

Schwartz M

series ordinal

2

1 reference

7 October 2017

1 January 1998

1 reference

7 October 2017

6

1 reference

inferred from page(s)

published in

Survey of Ophthalmology

1 reference

7 October 2017

42

1 reference

7 October 2017

4

1 reference

7 October 2017

367-372

1 reference

Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects.

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Temporal parameters of low energy laser irradiation for optimal delay of post-traumatic degeneration of rat optic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Strategies for neuroprotection with glutamate antagonists. Extrapolating from evidence taken from the first stroke and head injury studies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Glutamate neurotoxicity and diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Recovery of visual response of injured adult rat optic nerves treated with transglutaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Pharmacological strategies in CNS trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Mechanisms of optic nerve damage in primary open angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Programmed cell death of retinal ganglion cells during experimental glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Both NMDA and non-NMDA subtypes of glutamate receptors are concentrated at synapses on cerebral cortical neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Untreated ocular hypertension. A long-term prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

The epidemiology of open-angle glaucoma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Hydroxyl radicals generated in vivo kill neurons in the rat spinal cord: electrophysiological, histological, and neurochemical results

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Secondary mechanisms in neuronal trauma.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Clinical experience with excitatory amino acid antagonist drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

The Bedford glaucoma survey. I. Long-term follow-up of borderline cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

The pathobiology of traumatically induced axonal injury in animals and humans: a review of current thoughts

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Anoxic injury of CNS white matter: protective effect of ketamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

The nerve of glaucoma!

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Mechanisms of ischemic brain damage

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Compound action potential of nerve recorded by suction electrode: a theoretical and experimental analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

Pharmacotherapy in spinal cord injury: a critical review of recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900123-9

7 January 2021

10.1016/S0039-6257(97)00123-9

Identifiers

DOI

1 reference

7 October 2017

1 reference

PubMed ID

9493279